Marian T Nakada Selected Research

Marian T Nakada Research Topics

Disease

16	Neoplasms (Cancer) 10/2009 - 02/2002
7	Neoplasm Metastasis (Metastasis) 10/2009 - 05/2002
5	Breast Neoplasms (Breast Cancer) 01/2008 - 02/2004
2	Ischemia 01/2008 - 02/2002
2	Inflammation (Inflammations) 04/2006 - 03/2002
2	Cerebral Hemorrhage 11/2005 - 02/2002
2	Disease Progression 04/2005 - 02/2004
2	Melanoma (Melanoma, Malignant) 06/2004 - 05/2002
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2009
1	Stomach Neoplasms (Stomach Cancer) 10/2009
1	Colorectal Neoplasms (Colorectal Cancer) 10/2009
1	Carcinoma (Carcinomatosis) 06/2007
1	Fever (Fevers) 04/2007
1	Necrosis 04/2006
1	Glomerulonephritis 01/2006
1	Albuminuria 01/2006
1	Vasculitis (Vasculitides) 01/2006
1	Systemic Vasculitis 01/2006
1	Intracranial Thrombosis (Cerebral Thrombosis) 11/2005
1	Cerebral Infarction 11/2005
1	Ischemic Stroke 11/2005
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2004
1	Rheumatoid Arthritis 08/2004
1	Peripheral Arterial Occlusive Disease 1 02/2004
1	Thrombosis (Thrombus) 02/2004
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2004
1	Acute Coronary Syndrome 08/2002
1	Brain Ischemia (Cerebral Ischemia) 02/2002
1	Hemorrhage 02/2002
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2002
1	Infarction (Infarctions) 02/2002

Drug/Important Bio-Agent (IBA)

5	IntegrinsIBA 10/2007 - 05/2002
4	Matrix Metalloproteinases (MMPs)IBA 10/2009 - 02/2004
4	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 10/2009 - 02/2004
4	Integrin alphaVIBA 01/2008 - 06/2004
4	Monoclonal AntibodiesIBA 10/2007 - 02/2004
4	Abciximab (ReoPro)FDA Link 01/2006 - 05/2002
3	Metalloproteases (Metalloproteinases)IBA 10/2009 - 04/2005
3	intetumumabIBA 01/2008 - 06/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2006 - 02/2002
3	CytokinesIBA 04/2006 - 03/2002
3	AntibodiesIBA 01/2006 - 12/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 03/2002
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2005 - 02/2002
2	Antineoplastic Agents (Antineoplastics)IBA 06/2007 - 05/2002
2	Cytotoxins (Cytolysins)IBA 06/2007 - 04/2006
2	Therapeutic UsesIBA 01/2006 - 02/2002
2	reteplase FDA Link 11/2005 - 02/2004
2	Platelet Membrane GlycoproteinsIBA 11/2005 - 02/2004
2	EndopeptidasesIBA 04/2005 - 02/2004
2	Thrombin FDA Link 02/2004 - 02/2002
1	Keratin-18 (Keratin 18)IBA 10/2009
1	Biomarkers (Surrogate Marker)IBA 10/2009
1	EnzymesIBA 01/2008
1	CatalaseIBA 01/2008
1	VitronectinIBA 01/2008
1	Biological ProductsIBA 01/2008
1	Surface Antigens (Surface Antigen)IBA 06/2007
1	ProdrugsIBA 06/2007
1	Immunoconjugates (Immunoconjugate)IBA 06/2007
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2007
1	Thromboplastin (Tissue Factor)IBA 03/2007
1	Phosphotransferases (Kinase)IBA 06/2006
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 06/2006
1	MitogensIBA 04/2006
1	Peptide Hydrolases (Proteases)FDA Link 04/2006
1	ChemokinesIBA 04/2006
1	Chemotactic FactorsIBA 04/2006
1	Immunoglobulin G (IgG)IBA 01/2006
1	Integrin alphaVbeta3IBA 01/2006
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2006
1	Neutralizing AntibodiesIBA 04/2005
1	Recombinant DNA (Recombinant DNA Research)IBA 04/2005
1	Proteins (Proteins, Gene)FDA Link 04/2005
1	RNA (Ribonucleic Acid)IBA 04/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2005
1	MetalsIBA 02/2004
1	Eptifibatide (Integrilin)FDA Link 08/2002
1	Tirofiban (Aggrastat)FDA Link 08/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2002
1	Indicators and Reagents (Reagents)IBA 03/2002
1	Platelet Membrane Glycoprotein IIbIBA 02/2002
1	Dihydrotachysterol (AT 10)IBA 02/2002
1	Hemostatics (Antihemorrhagics)IBA 02/2002
1	Glycoproteins (Glycoprotein)IBA 02/2002
1	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2002

Therapy/Procedure

5	Therapeutics 10/2007 - 02/2002